Understanding how craving affects decision-making in opioid use disorder
Official title: Decision Neuroscience of Craving
Run by Rutgers, The State University of New Jersey · NCT06440577 · Data updated 2026-11-12
This study is testing how cravings for opioids affect the choices people with opioid use disorder make when deciding what to buy, using brain scans to see what's happening in their minds during the process.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Piscataway, New Jersey) |
| Status | Recruiting |
| Started | June 18, 2024 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT06440577 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older who have a primary diagnosis of opioid use disorder and are receiving outpatient treatment.
✕Probably not a fit
Patients who are not fluent in English or have severe psychiatric or neurological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the relationship between craving and decision-making in individuals with opioid use disorder (OUD). It employs cognitive decision-making tasks to assess how much participants are willing to pay for consumer items or snack foods when experiencing cravings for opioids or specific snacks. The research aims to uncover the neural mechanisms that link craving with the valuation of choices, utilizing various audio-visual stimuli to evoke cravings during the decision-making process. Participants will be monitored using brain imaging techniques to analyze the activity patterns in regions associated with craving and value assignment.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for individuals with opioid use disorder by enhancing understanding of craving's impact on decision-making.
How similar studies have gone: While studies have explored craving and decision-making separately, this specific approach examining their interaction in opioid use disorder is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years of age * Willingness to follow study requirements, as evidenced by an ability to provide written informed consent and read, understand, and complete the study procedures * Minimum of 6th grade reading level Additional inclusion criteria for participants with OUD: * Primary diagnosis of OUD encompassing heroin and/or painkiller use * Receiving medications for OUD treatment on an outpatient basis * At least 12-month history of opioid use Exclusion Criteria: * Unable to speak or read English * Active psychosis or mania * Current or past schizophrenia diagnosis * History of intellectual disability or developmental or neurological disorder, seizures or epilepsy, or loss consciousness lasting more than 30 minutes * Severe medical conditions requiring hospitalization or that, in the opinion of the study staff could compromise study participation * MRI contraindications (claustrophobia, nonremovable piercings, certain metal in the body etc.) or pregnancy Additional exclusion criteria for community control participants: * Positive urine drug screen * Current or past problematic substance use other than nicotine, and alcohol abuse confined to college or military service * Current or past bipolar disorder diagnosis * Use of central nervous system medications within the past 6 weeks (e.g., antidepressants, Ritalin)
Where it's running
-
Rutgers, The State University of New Jersey
Piscataway, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Anna Konova, PhD — Rutgers, The State University of New Jersey
- Study coordinator: Anna Konova, PhD
- Email: anna.konova@rutgers.edu
- Phone: 732-235-4335
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How vaccine-related inflammation may affect how doctors make treatment decisions
This study tests whether a mild inflammatory state from a flu shot changes decision-making in emergency and internal medicine clinicians.
-
Testing Alcohol Health Warning Labels for US Adults
A randomized online study will test different warning statements about alcohol and breast cancer risk among adult US women who drink or are young non-drinkers to see which warnings are most convincing.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Heart rate variability feedback to help practitioners make better patient decisions
This study tests whether giving healthcare workers HRV feedback during care improves how quickly and safely they respond to ventilator events and bedside needs.
-
Testing warning labels on cannabis packaging to see what design helps people notice risks
Researchers are testing different cannabis warning labels to see which designs make people notice health risks and think about their use more carefully.
-
Support for Just-In-Time Consent for Prenatal Screening
This study tests a short set of information cards delivered on a phone to help pregnant people decide about prenatal screening.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.